AbbVie Inc. Stock Underperforms Tuesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of AbbVie Inc. (ABBV) shed 1.25% to $159.64 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.70% to 3,919.25 and the Dow Jones Industrial Average rising 0.56% to 33,704.10. This was the stock's second consecutive day of losses. AbbVie Inc. closed $16.27 below its 52-week high ($175.91), which the company reached on April 8th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson (JNJ) fell 0.24% to $175.16 and Pfizer Inc. (PFE) fell 1.59% to $47.62. Trading volume (5.9 M) eclipsed its 50-day average volume of 5.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 10, 2023.
(END) Dow Jones Newswires
January 10, 2023 16:33 ET (21:33 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.